Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Biotechnology
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 08, 2024 7:00am
New Press Release - Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
MISSISSAUGA, ON, March 8, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and full year of 2023 after the market close on Thursday, March 14, 2024. The Company will...
read article.
(1775)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Feb 26, 2024 3:06pm
smallcapdiscoveries.com - Bucking the Trend
Bucking the Trend It’s no secret that 2023 was a rough year for the smallcap market. A simple snapshot of the TSX Venture index shows this story quite clearly: Inflation, high
...more
(6253)
•••
retiredcf
X
Post by
retiredcf
on Feb 25, 2024 7:30am
Interesting
Your profile on Cipher Pharma lists only 5 employees - how accurate and current are such numbers? Also you dropped coverage on this stock in 2018 "until some visibility emerges." which now
...more
(6253)
•••
retiredcf
X
Post by
retiredcf
on Feb 15, 2024 1:20pm
Stifel
CPH is his second pick. GLTA Hot Picks: Low valuations means opportunity for investing in these three pharma stocks Canada's pharma sector is challenged says Justin Keywood, healthcare and
...more
(1775)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Feb 14, 2024 3:15pm
Citigroup catches up
Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) had its price target raised by analysts at Citigroup Inc. from C$4.75 to C$8.00. They now have a "buy" rating on the stock. This
...more
(6253)
•••
retiredcf
X
Post by
retiredcf
on Feb 14, 2024 7:36am
Target Raised by 68%
Seeing “limited downside risk and potential torque with M&A as a market cap size approaches what is palatable for small cap investing,” Stifel’s Justin Keywood raised Oakville, Ont.-based
...more
(6253)
•••
retiredcf
X
Post by
retiredcf
on Feb 09, 2024 3:47pm
Finally
Had wanted to add to my holdings but the SP got away from me. Took advantage of today's drop, to finally pick up a few more. Long and strong. GLTA
(2)
•••
Spuds69
X
Comment by
Spuds69
on Jan 30, 2024 1:16pm
RE:RE:RE:RE:New competitor to Epuris launches in Canada
Mull is talking out of both sides of his mouth. Look at the public disclosure from when they announced the deal on Absorica LD with Sun originally (Cipher Pharmaceuticals Announces Amended
...more
(14)
•••
drewmumaw
X
Comment by
drewmumaw
on Jan 24, 2024 10:44am
RE:RE:RE:New competitor to Epuris launches in Canada
https://youtu.be/LO3_6q9dE5U?feature=shared&t=1557 From 26:00 to 29:00. Essentially saying it flopped in the US and they think it will flop in Canada.
(7)
•••
Alex1726
X
Comment by
Alex1726
on Jan 23, 2024 5:12pm
RE:RE:New competitor to Epuris launches in Canada
What was said we have no access to this call no mre. Thanks.
(14)
•••
drewmumaw
X
Comment by
drewmumaw
on Jan 18, 2024 8:25pm
RE:New competitor to Epuris launches in Canada
This was discussed in the Q2 2023 call around the 26:00 minute mark.
(6253)
•••
retiredcf
X
Post by
retiredcf
on Dec 29, 2023 9:34am
Keystone Financial
KeyStone’s Latest Small-Cap Growth Stock Recommendation: Cipher Pharmaceuticals (CPH:TSX) Recommended: August 28, 2023, at $3.89 Today's Price: $5.70 Gain: 46.5% Cipher (CPH
...more
(6253)
•••
retiredcf
X
Post by
retiredcf
on Dec 05, 2023 7:07am
Assessment
CPH has performed strongly year-to-date (up 63.5%) and particularly spiked up in the last month (+44%). The recent Q3 earnings were likely the reason for the rally. Revenue was up 26.6% to $6.1M and
...more
(2)
•••
Spuds69
X
Post by
Spuds69
on Dec 04, 2023 4:29pm
New competitor to Epuris launches in Canada
FYI - Sun Pharma Canada Launches (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Acne (yahoo.com) Unbelievable that this product has been approved since June 2023 and this
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 24, 2023 5:00pm
New Press Release - Cipher Pharmaceuticals Announces Change of Auditor
MISSISSAUGA, ON, Nov. 24, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it has changed its auditors from Ernst & Young LLP ("Former Auditor") to RSM Canada LLP ("Successor Auditor") effective November 23, 2023. At the request of the Company...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Canadian clean tech company pioneering the upcycling of used motor oil into high value Group III base oils
A Canadian mineral company at the crossroads of electrification and defense
Maiden Resource Estimate of 54 Moz at 284 gpt Silver, Highlights High-Grade Potential at Columba
Eminent Continues to Hit Gold Mineralization at its Hot Springs Range Project in Nevada
Gold rush 2025: Why Desert Gold Ventures Inc. is now on the brink of a historic revaluation!
Freegold Achieves over 90% Gold Recovery Using BIOX® and greater than 92% Gold Recovery using POX